Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis.
Kennedy
N
N
University of Division of Communicable Diseases, Royal Free Hospital School of Medicine, London.
Fox
R
R
Uiso
L
L
Ngowi
F I
FI
Gillespie
S H
SH
D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D013636:Tanzania; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D002939:Ciprofloxacin